Azimi, G.; Elremaly, W.; Elbakry, M.; Franco, A.; Godbout, C.; Moreau, A.
Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia. Int. J. Mol. Sci. 2025, 26, 7670.
https://doi.org/10.3390/ijms26167670
AMA Style
Azimi G, Elremaly W, Elbakry M, Franco A, Godbout C, Moreau A.
Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia. International Journal of Molecular Sciences. 2025; 26(16):7670.
https://doi.org/10.3390/ijms26167670
Chicago/Turabian Style
Azimi, Ghazaleh, Wesam Elremaly, Mohamed Elbakry, Anita Franco, Christian Godbout, and Alain Moreau.
2025. "Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia" International Journal of Molecular Sciences 26, no. 16: 7670.
https://doi.org/10.3390/ijms26167670
APA Style
Azimi, G., Elremaly, W., Elbakry, M., Franco, A., Godbout, C., & Moreau, A.
(2025). Circulating FGF-21 as a Disease-Modifying Factor Associated with Distinct Symptoms and Cognitive Profiles in Myalgic Encephalomyelitis and Fibromyalgia. International Journal of Molecular Sciences, 26(16), 7670.
https://doi.org/10.3390/ijms26167670
